Partnership Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Partnership Wealth Management, LLC

  • $142 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024
SELL
$392.81 - $485.53 $230,972 - $285,491
-588 Reduced 33.68%
1,158 $543 Million
Q1 2024

Apr 10, 2024
SELL
$407.69 - $446.08 $251,952 - $275,677
-618 Reduced 26.14%
1,746 $730 Million
Q4 2023

Feb 07, 2024
BUY
$343.0 - $410.68 $810,852 - $970,847
2,364 New
2,364 $1.02 Billion

Others Institutions Holding VRTX

# of Institutions
1,716
Shares Held
225M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Partnership Wealth Management, LLC Portfolio

Follow Partnership Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partnership Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Partnership Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email